B. Braun Coordinated Vulnerability Disclosure
To ensure high security standards throughout the entire product life cycle, B. Braun uses globally accepted standard testing and verification methods. We have established processes to monitor the latest vulnerabilities, threats and risks and will proactively implement measures as required.
B. Braun is now an authorized CVE Numbering Authority (CNA) for our devices and supporting systems. We manage the assignment, transparency and resolutions of our CVE identifiers of cyber vulnerabilities.
We welcome vulnerability reports from researchers, industry groups, CERTs, partners and any other source. We will give full credit on our website once the submission has been accepted and validated by our product security team.
B. Braun’s Vulnerability Disclosure Program initially covers medical devices, combination products and healthcare related software.
-Your reference/advisory number and sufficient contact information.
- A technical description of the concern or vulnerability.
- On which specific product you tested, including product name and version number.
- The technical infrastructure that was tested including operating system, version and network configuration details.
- For web-based services, the date and time of testing, URLs, the browser type, version as well as the input provided to the application.
-Any additional information, including details on the tools used to conduct the testing and any relevant test configurations. If you wrote specific proof-of-concept or exploit code, please provide a copy.
-If you have identified specific threats related to the vulnerability, assessed the risk, or have seen the vulnerability being exploited, please provide that information.
-If you communicate vulnerability information to vulnerability coordinators such as ICS-CERT, CERT/CC, NCSC or other parties, please include their tracking number if available.
What you can expect from us
- A timely response to your email (within 2 business days).
- After triage, we will send an expected timeline and commit to being as transparent as possible about the remediation timeline or challenges that may extend it.
- An open dialog to discuss issues.
- Notification when the vulnerability analysis has completed each stage of our review.
- Credit after the vulnerability has been validated and fixed.
- Public reporting of vulnerability in appropriate circumstances.
We will not engage in legal action against individuals who submit reports through our vulnerability reporting process and enter into a legal agreement with us. We agree to work with individuals who:
-Engage in testing of systems/research without harming B. Braun or its customers and certainly patients.
-Adhere to the laws of their location and the location of B. Braun.
-Engage in vulnerability testing within the scope of our vulnerability disclosure program in accordance with the terms and conditions of any agreements entered into between B. Braun and individuals.
-Refrain from disclosing vulnerability details before any mutually agreed-upon timeframe expires.
-The discloser’s actions must not be disproportionate or in bad faith, such as:
- Using social engineering to gain access to the system.
- Building his or her own backdoor in an information system with the intention of then using it to demonstrate the vulnerability.
- Utilizing a vulnerability further than necessary to establish its existence.
- Copying, modifying or deleting data on the system or making changes to it.
- Repeatedly gaining access to the system or sharing access with others.